Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease

US Patent 9896505 · Granted Feb 20, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interferon beta antibodies and uses thereof2025
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules2025
Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)2024
Bispecific binding proteins and uses thereof2024
Interferon beta antibodies and uses thereof2024
Molecules with altered neonate Fc receptor binding having enhanced therapeutic a2023
ILT7 binding molecules and methods of using the same2023
Antibodies directed against Staphylococcus aureus leukotoxins2023
Methods of administering a composition comprising a Tn3 scaffold and a CD40L-spe2023
Methods of administering a composition comprising a Tn3 scaffold and a CD40L-spe2023
Antibodies specific for IL-21 and uses thereof2022
Antibodies specific for IL-21 and uses thereof2022